7.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Cvrx Inc Borsa (CVRX) Ultime notizie
CVRx’s Barostim therapy receives Category I CPT codes By Investing.com - Investing.com India
Cvrx announces implementation of new category I CPT codes for Barostim therapy - marketscreener.com
CVRx announces implementation of new category I CPT codes for Barostim therapy - TipRanks
CVRx, Inc. Announces Transition to Category I CPT Codes for Barostim Therapy Effective January 1, 2026 - Quiver Quantitative
CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy - The Manila Times
CVRx signals gratitude towards healthcare community amid heart failure treatment advancements - Traders Union
Institution Moves: Can CVRX stock resist market sell offs2025 Momentum Check & Long-Term Growth Portfolio Plans - moha.gov.vn
Technical Reactions to CVRX Trends in Macro Strategies - Stock Traders Daily
CVRx, Inc.'s (NASDAQ:CVRX) Popularity With Investors Under Threat As Stock Sinks 26% - simplywall.st
CVRx upgraded by William Blair to outperform - MSN
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference - Sahm
CVRx supports St. Cloud Hospital with Barostim implants - Traders Union
CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Why CVRx Inc. stock is a must watch in 2025July 2025 Setups & Community Verified Swing Trade Signals - Улправда
Will CVRX stock reach Wall Street targetsJuly 2025 Recap & Fast Moving Market Watchlists - Bölüm Sonu Canavarı
Why CVRx Inc. stock is favored by pension funds2025 Major Catalysts & Risk Managed Trade Strategies - Улправда
Earnings Report: Will CVRX stock deliver long term returnsJuly 2025 Patterns & Long-Term Capital Growth Strategies - Bollywood Helpline
CVRx marks milestone with 25 Barostim implants at Los Robles - Traders Union
Discipline and Rules-Based Execution in CVRX Response - Stock Traders Daily
Why CVRx Inc. stock remains a top recommendation - Улправда
Is CVRx Inc. stock positioned for long term growthJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - DonanımHaber
What analyst consensus says on CVRX stock2025 Growth vs Value & Accurate Technical Buy Alerts - Улправда
How resilient is CVRX stock in market downturnsJuly 2025 Big Picture & Precise Buy Zone Identification - DonanımHaber
Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Novan (NOVN) and CVRx (CVRX) - The Globe and Mail
Is CVRX stock a buy on dips2025 Price Momentum & AI Powered Trade Plan Recommendations - Улправда
Earnings Risk: Why CVRx Inc. stock is a must watch in 2025July 2025 Rallies & Stock Portfolio Risk Management - Улправда
How CVRx Inc. stock reacts to Fed rate cutsWeekly Investment Recap & Fast Moving Stock Trade Plans - Улправда
Will CVRX stock outperform tech sector in 2025Earnings Growth Summary & Real-Time Volume Analysis Alerts - Улправда
CVRx hosts webinar on Barostim coding updates ahead of 2026 - Traders Union
CVRx Earnings Notes - Trefis
CVRx prepares for Jan 2026 Barostim billing update - Traders Union
Behavioral Patterns of CVRX and Institutional Flows - news.stocktradersdaily.com
Would You Still Hold CVRx Stock If It Fell Another 30%? - Trefis
Is CVRx Inc. stock supported by strong fundamentals2025 Market Sentiment & Risk Managed Trade Strategies - Newser
Why CVRX stock could rally in 20252025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Johnson & Johnson's Strategic Adjustment in CVRx Inc Holdings - GuruFocus
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 - Investing.com India
Johnson & Johnson Makes a Bold Move with CVRx Stock Sale! - TipRanks
Johnson & Johnson sells CVRx (CVRX) shares worth $63,560 By Investing.com - Investing.com Australia
Jobs Data: Will CVRX stock deliver long term returnsMarket Sentiment Review & Capital Efficient Trading Techniques - BỘ NỘI VỤ
CVRX 8-K & SEC Filings - Yahoo Finance
Will CVRX stock deliver long term returnsJuly 2025 Volume & Low Volatility Stock Recommendations - BỘ NỘI VỤ
CVRx stock slides on preliminary revenue miss - MSN
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
CVRx (CVRX) Gets a Buy from Canaccord Genuity - The Globe and Mail
Johnson & Johnson Makes a Strategic Move with CVRx Stock Sale! - TipRanks
CVRx stock holds Buy rating at Canaccord as CMS finalizes 2026 payment - Investing.com Nigeria
Johnson & Johnson innovation sells $27,132 in CVRx shares By Investing.com - Investing.com South Africa
Johnson & Johnson innovation sells $27,132 in CVRx shares - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):